Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy
Objectives: To assess the clinical outcomes of prostate cancer patients treated with salvage radiotherapy (SRT) for locoregional clinical recurrence (CR) after radical prostatectomy (RP). Methods: Records of 60 patients with macroscopic locoregional recurrence after prostatectomy and referrals for S...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/802cb9337c2c4010bb15c0453bb9e04e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:802cb9337c2c4010bb15c0453bb9e04e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:802cb9337c2c4010bb15c0453bb9e04e2021-11-21T02:04:41ZClinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy1533-033810.1177/15330338211041212https://doaj.org/article/802cb9337c2c4010bb15c0453bb9e04e2021-11-01T00:00:00Zhttps://doi.org/10.1177/15330338211041212https://doaj.org/toc/1533-0338Objectives: To assess the clinical outcomes of prostate cancer patients treated with salvage radiotherapy (SRT) for locoregional clinical recurrence (CR) after radical prostatectomy (RP). Methods: Records of 60 patients with macroscopic locoregional recurrence after prostatectomy and referrals for SRT were retrospectively investigated in the multi-institutional database. The median radiation dose was 70.2 Gy. Biochemical failure was defined as the prostate-specific antigen (PSA) ≥ nadir + 2 or initiation of androgen deprivation therapy (ADT) for increased PSA. Results: Median recurrent tumor size was 1.1 cm and pre-radiotherapy PSA level was 0.4 ng/ml. At a median follow-up of 83.1-month after SRT, 7-year biochemical failure-free survival (BCFFS), locoregional failure-free survival (LRFFS), distant metastasis-free survival (DMFS), and overall survival (OS) were 67.0%, 89.7%, 83.6%, and 91.2%, respectively. Higher Gleason's scores were associated with unfavorable BCFFS, DMFS, and OS. Pre-SRT PSA ≥0.5 ng/ml predicted worse BCFFS, LRFFS, and DMFS. In multivariate analyses, a Gleason's score of 8 to 10 was associated with decreased BCFFS (hazard ratio [HR] 3.12, 95% confidence interval [CI] 1.11-8.74, P = .031) and OS (HR 17.72, 95% CI 1.75-179.64, P = .015), and combined ADT decreased the risks of distant metastasis (HR 0.18, 95% CI 0.04-0.92, P = .039). Two patients (3.3%) experienced late grade 3 urinary toxicity. Conclusions: SRT for locoregional CR after RP achieved favorable outcomes with acceptable long-term toxicities. Higher Gleason's scores and pre-radiotherapy PSA level were unfavorable prognostic variables. Combined ADT may decrease the risks of metastases.Sung Uk Lee MDKwan Ho Cho MDJin Ho Kim MDYoung Seok Kim MDTaek-Keun Nam MDJae-Sung Kim MDJaeho Cho MDSeo Hee Choi MDSu Jung Shim MDJin Hee Kim MDAh Ram Chang MDSAGE PublishingarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENTechnology in Cancer Research & Treatment, Vol 20 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Sung Uk Lee MD Kwan Ho Cho MD Jin Ho Kim MD Young Seok Kim MD Taek-Keun Nam MD Jae-Sung Kim MD Jaeho Cho MD Seo Hee Choi MD Su Jung Shim MD Jin Hee Kim MD Ah Ram Chang MD Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy |
description |
Objectives: To assess the clinical outcomes of prostate cancer patients treated with salvage radiotherapy (SRT) for locoregional clinical recurrence (CR) after radical prostatectomy (RP). Methods: Records of 60 patients with macroscopic locoregional recurrence after prostatectomy and referrals for SRT were retrospectively investigated in the multi-institutional database. The median radiation dose was 70.2 Gy. Biochemical failure was defined as the prostate-specific antigen (PSA) ≥ nadir + 2 or initiation of androgen deprivation therapy (ADT) for increased PSA. Results: Median recurrent tumor size was 1.1 cm and pre-radiotherapy PSA level was 0.4 ng/ml. At a median follow-up of 83.1-month after SRT, 7-year biochemical failure-free survival (BCFFS), locoregional failure-free survival (LRFFS), distant metastasis-free survival (DMFS), and overall survival (OS) were 67.0%, 89.7%, 83.6%, and 91.2%, respectively. Higher Gleason's scores were associated with unfavorable BCFFS, DMFS, and OS. Pre-SRT PSA ≥0.5 ng/ml predicted worse BCFFS, LRFFS, and DMFS. In multivariate analyses, a Gleason's score of 8 to 10 was associated with decreased BCFFS (hazard ratio [HR] 3.12, 95% confidence interval [CI] 1.11-8.74, P = .031) and OS (HR 17.72, 95% CI 1.75-179.64, P = .015), and combined ADT decreased the risks of distant metastasis (HR 0.18, 95% CI 0.04-0.92, P = .039). Two patients (3.3%) experienced late grade 3 urinary toxicity. Conclusions: SRT for locoregional CR after RP achieved favorable outcomes with acceptable long-term toxicities. Higher Gleason's scores and pre-radiotherapy PSA level were unfavorable prognostic variables. Combined ADT may decrease the risks of metastases. |
format |
article |
author |
Sung Uk Lee MD Kwan Ho Cho MD Jin Ho Kim MD Young Seok Kim MD Taek-Keun Nam MD Jae-Sung Kim MD Jaeho Cho MD Seo Hee Choi MD Su Jung Shim MD Jin Hee Kim MD Ah Ram Chang MD |
author_facet |
Sung Uk Lee MD Kwan Ho Cho MD Jin Ho Kim MD Young Seok Kim MD Taek-Keun Nam MD Jae-Sung Kim MD Jaeho Cho MD Seo Hee Choi MD Su Jung Shim MD Jin Hee Kim MD Ah Ram Chang MD |
author_sort |
Sung Uk Lee MD |
title |
Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy |
title_short |
Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy |
title_full |
Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy |
title_fullStr |
Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy |
title_full_unstemmed |
Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy |
title_sort |
clinical outcome of salvage radiotherapy for locoregional clinical recurrence after radical prostatectomy |
publisher |
SAGE Publishing |
publishDate |
2021 |
url |
https://doaj.org/article/802cb9337c2c4010bb15c0453bb9e04e |
work_keys_str_mv |
AT sungukleemd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT kwanhochomd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT jinhokimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT youngseokkimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT taekkeunnammd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT jaesungkimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT jaehochomd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT seoheechoimd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT sujungshimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT jinheekimmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy AT ahramchangmd clinicaloutcomeofsalvageradiotherapyforlocoregionalclinicalrecurrenceafterradicalprostatectomy |
_version_ |
1718419374518304768 |